Total Payments
$84,673
2024 Payments
$38,558
Companies
37
Transactions
607
Medicare Patients
1,781
Medicare Billing
$158,644
Payment Breakdown by Category
Other$67,480 (79.7%)
Food & Beverage$12,087 (14.3%)
Travel$3,460 (4.1%)
Consulting$1,600 (1.9%)
Education$45.66 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $67,480 | 44 | 79.7% |
| Food and Beverage | $12,087 | 537 | 14.3% |
| Travel and Lodging | $3,460 | 21 | 4.1% |
| Consulting Fee | $1,600 | 1 | 1.9% |
| Education | $45.66 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | $32,055 | 48 | $0 (2024) |
| ABBVIE INC. | $21,182 | 164 | $0 (2024) |
| Allergan, Inc. | $18,204 | 50 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $5,440 | 59 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $2,465 | 8 | $0 (2024) |
| Celgene Corporation | $731.81 | 46 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $601.33 | 33 | $0 (2024) |
| PFIZER INC. | $574.63 | 39 | $0 (2024) |
| Janssen Biotech, Inc. | $457.26 | 21 | $0 (2024) |
| Ardelyx, Inc. | $382.72 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38,558 | 166 | Phathom Pharmaceuticals, Inc. ($32,055) |
| 2023 | $11,959 | 111 | ABBVIE INC. ($8,201) |
| 2022 | $4,716 | 83 | ABBVIE INC. ($3,856) |
| 2021 | $7,370 | 57 | Takeda Pharmaceuticals U.S.A., Inc. ($4,556) |
| 2020 | $2,053 | 16 | Allergan, Inc. ($1,848) |
| 2019 | $5,472 | 61 | Allergan Inc. ($4,736) |
| 2018 | $2,793 | 53 | AbbVie, Inc. ($1,885) |
| 2017 | $11,751 | 60 | Allergan Inc. ($11,068) |
All Payment Transactions
607 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Immunology | ||||||
| 12/16/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $230.46 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | Cash or cash equivalent | $69.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/06/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $22.01 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,440.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,290.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $627.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $245.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | Cash or cash equivalent | $54.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $246.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $177.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $121.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $81.46 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 484 | 517 | $203,289 | $45,049 |
| 2022 | 9 | 439 | 470 | $177,133 | $40,031 |
| 2021 | 9 | 377 | 410 | $135,563 | $33,875 |
| 2020 | 11 | 481 | 509 | $176,444 | $39,689 |
Total Patients
1,781
Total Services
1,906
Medicare Billing
$158,644
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 84 | 84 | $91,728 | $17,326 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 129 | $20,124 | $10,976 | 54.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 43 | 44 | $22,316 | $3,063 | 13.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 17 | 17 | $12,971 | $2,980 | 23.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $7,700 | $2,902 | 37.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 48 | 48 | $27,192 | $2,836 | 10.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 44 | $4,664 | $2,458 | 52.7% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 12 | 13 | $7,722 | $1,211 | 15.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $6,468 | $922.74 | 14.3% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 75 | 75 | $1,875 | $243.33 | 13.0% |
| 99153 | Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | Facility | 2023 | 23 | 23 | $529.00 | $132.02 | 25.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 83 | 84 | $91,460 | $17,237 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 113 | $17,628 | $10,434 | 59.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $7,425 | $3,292 | 44.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 47 | 47 | $23,142 | $3,038 | 13.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 37 | 37 | $21,836 | $2,687 | 12.3% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 17 | 18 | $10,692 | $1,796 | 16.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 18 | $1,908 | $854.50 | 44.8% |
| 99153 | Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | Facility | 2022 | 53 | 54 | $1,242 | $427.29 | 34.4% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 69 | 72 | $1,800 | $264.21 | 14.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 57 | 57 | $62,244 | $11,848 | 19.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 80 | 106 | $16,536 | $10,031 | 60.7% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 45 | 45 | $25,956 | $3,313 | 12.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 25 | 25 | $6,875 | $3,281 | 47.7% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 31 | 32 | $17,081 | $2,518 | 14.7% |
About Dr. Peter Le, M.D
Dr. Peter Le, M.D is a Gastroenterology healthcare provider based in Castle Rock, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2008. The National Provider Identifier (NPI) number assigned to this provider is 1942460209.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Le, M.D has received a total of $84,673 in payments from pharmaceutical and medical device companies, with $38,558 received in 2024. These payments were reported across 607 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($67,480).
As a Medicare-enrolled provider, Le has provided services to 1,781 Medicare beneficiaries, totaling 1,906 services with total Medicare billing of $158,644. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Castle Rock, CO
- Active Since 06/11/2008
- Last Updated 08/23/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1942460209
Products in Payments
- LINZESS (Drug) $34,423
- VOQUEZNA (Drug) $32,055
- MOTEGRITY (Drug) $4,427
- Linzess (Drug) $2,453
- Humira (Biological) $2,050
- RINVOQ (Biological) $929.42
- ZEPOSIA (Drug) $731.81
- VIBERZI (Drug) $605.64
- ENTYVIO (Biological) $570.89
- SKYRIZI (Biological) $557.51
- XELJANZ (Drug) $531.27
- XIFAXAN (Drug) $521.44
- STELARA (Biological) $428.11
- HUMIRA (Biological) $401.41
- IBSRELA (Drug) $382.72
- DUPIXENT (Biological) $377.14
- Entyvio (Biological) $253.69
- SUCRAID (Drug) $176.28
- OCALIVA (Drug) $171.30
- TREMFYA (Drug) $153.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.